Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
MEDXF
Primary Symbol:
T.MDP
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA...
. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(39)
•••
Rockafellow2
X
View Profile
View Bullboard History
Post by
Rockafellow2
on Nov 08, 2022 3:44pm
Must b good news
Coming!
(80)
•••
bingostar
X
View Profile
View Bullboard History
Post by
bingostar
on Nov 02, 2022 12:00pm
Q2
TORONTO and CHICAGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (Medexus) (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on
...more
TAG Oil Announces Successful Production Test Results from BED4-T100 Horizontal Well
posted May 17, 2024 9:00am by
TAG Oil Ltd.
-
|
"We are pleased with the performance of our first well in the ARF resource play despite encountering drilling challenges resulting in a shorter lateral section of 308 meters. Looking ahead, TAG Oil plans to drill horizontal wells with lateral lengths of up to 1,000 meters, accompanied by three times ...read more
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on Oct 12, 2022 10:16am
RE:Still moving up
The best looking chart on the TSE, where are the broker covering this story... if anyone as info on what they are saying,thanks for sharing.
(39)
•••
Rockafellow2
X
View Profile
View Bullboard History
Post by
Rockafellow2
on Oct 11, 2022 4:39pm
Still moving up
Slowly ... Big profits last quarter ... Something amiss ...???
(3)
•••
existabo
X
View Profile
View Bullboard History
Post by
existabo
on Oct 06, 2022 1:17pm
Record numbers and no real run up...
Amazing report this morning, PE :6.90, big potential coming from TREO . Surprising since 4 brokers are covering the stocks, all buys and yet hardly no volume nor run up !
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Sep 20, 2022 3:46pm
Wow! Bad News yesterday
Sorry to hear the bad news. I'm glad I got out with a small loss long time ago but I definitely feel for all those who hung in there. I thought the FDA would approve Treo and was going to jump in
...more
(157)
•••
cleareye
X
View Profile
View Bullboard History
Post by
cleareye
on Jun 23, 2022 3:39am
Q4
Q4 is out. Financial Highlights Delivered total revenue of $20.3 million in fiscal Q4 2022, an increase of 15% compared to fiscal Q4 2021 and, as expected, a decrease of 5% compared to fiscal
...more
(39)
•••
Rockafellow2
X
View Profile
View Bullboard History
Post by
Rockafellow2
on May 20, 2022 11:12am
When ... ?
Next fins ...?
(39)
•••
Rockafellow2
X
View Profile
View Bullboard History
Comment by
Rockafellow2
on May 06, 2022 10:47am
RE:Deal for Gleolan in the United States
When ???????
(1931)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 01, 2022 7:35am
Deal for Gleolan in the United States
Medexus has acquired exclusive rights to commercialize Gleolan in the United States, complementing Medexus’s existing rights to Gleolan in Canada Gleolan is an optical imaging agent currently
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jan 11, 2022 12:08pm
EyePoint: Appoints Michael C. Pine as Chief of Dev+Strategy
Not sure how this will effect MDP but it is definitely is a good move for Pine. "Most recently, Mr. Pine was a Senior Vice President of Business Development and Strategy at Medexus
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Dec 30, 2021 9:53am
RE:RE:Type A Meeting with FDA Granted for Treosulfan
Excellent news on the Type A meeting but we are still 2 to 6 months out. Hoping to hear excellent numbers in the next financials. I've moved my buy in up by 4 months. I'll be looking to get
...more
(16)
•••
russter
X
View Profile
View Bullboard History
Comment by
russter
on Nov 18, 2021 3:58pm
RE:Type A Meeting with FDA Granted for Treosulfan
Lets hope the type A's have a productive meeting and clear way forward. So we can get back to where it should be trading. I was grateful for the dip so I could av dn. Thanks all! Russ
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Nov 09, 2021 3:49pm
I bailed last week
I maybe back in 6 months or so.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Nov 03, 2021 3:40pm
Good price action on low volume
up 6.3%. I'm wondering about the Type A meeting. If it is just about the numbers then approval could be 60 to 90+ away, depending on how fast they can present the data. I'm not sure about this
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service